Giant Biogene Holding Co Ltd (2367)

Currency in HKD
18.85
-0.28(-1.46%)
Closed·
Trading near 52-week Low
High dividend Yield
2367 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
18.4019.10
52 wk Range
18.4041.32
Key Statistics
Bid/Ask
18.85 / 18.85
Prev. Close
18.85
Open
19.1
Day's Range
18.4-19.1
52 wk Range
18.4-41.32
Volume
3.72M
Average Volume (3m)
3.69M
1-Year Change
-48.9989%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
2367 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
35.31
Upside
+87.31%
Members' Sentiments
Bearish
Bullish
ProTips
High shareholder yield
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Analyst Ratings

12 Buy
3 Hold
1 Sell
Ratings:
16 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 35.31
(+87.31% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Citi
Buy29.30+55.44%38.40MaintainNov 19, 2026
Macquarie
Buy46.00+144.03%45.30MaintainAug 20, 2026
HSBC
Hold29.50+56.50%33.40DowngradeJul 22, 2026
Macquarie
Buy45.30+140.32%50.60MaintainJul 21, 2026
Macquarie
Buy50.60+168.44%-MaintainJun 18, 2026

Earnings

Latest Release
Sep 23, 2025
EPS / Forecast
1.13 / 1.38
Revenue / Forecast
3.11B / --
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 1.83
Dividend Yield
7.26%
Industry Median 5.72%
Annualized payout
1.39
Paid unevenly
5-Years Growth
-
Growth Streak

2367 Income Statement

Compare 2367 to Peers and Sector

Metrics to compare
2367
Peers
Sector
Relationship
P/E Ratio
10.2x18.2x10.6x
PEG Ratio
−0.350.180.03
Price/Book
1.8x1.7x1.5x
Price / LTM Sales
3.2x1.6x0.8x
Upside (Analyst Target)
87.3%16.3%23.1%
Fair Value Upside
Unlock20.4%14.8%Unlock

Giant Biogene Holding Co., Ltd., an investment holding company, engages in the research, development, manufacture, and sale of bioactive material-based beauty and health products in the People’s Republic of China. It offers functional skincare products, medical dressings and devices, and functional food products under the KOMFYMED, Collgene, Ke Yu, SKIGIN, and other brands. The company also develops and manufactures rare ginsenosides technology-based functional food products. In addition, it provides aesthetic services. The company was founded in 2000 and is headquartered in Xi'an, the People’s Republic of China.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
109.34M10.30%2.06B
Other Institutional Investors
-40.50K-0.00%-763.50K
Public Companies & Retail Investors
952.41M89.71%17.95B
Total
1.06B100.00%20.01B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Vanguard Capital Management, LLC1.95%20,698,378390,164
BlackRock, Inc.1.18%12,521,238236,025

People Also Watch

26.42
2577
-0.23%
31.68
1651
-2.70%
4.92
2650
-2.38%

FAQ

What Is the Giant Biogene Holding (2367) Stock Price Today?

The Giant Biogene Holding stock price today is 18.85 HKD.

What Stock Exchange Does Giant Biogene Holding Trade On?

Giant Biogene Holding is listed and trades on the Hong Kong Stock Exchange.

What Is the Stock Symbol for Giant Biogene Holding?

The stock symbol for Giant Biogene Holding is "2367."

Does Giant Biogene Holding Pay Dividends? What’s The Current Dividend Yield?

The Giant Biogene Holding dividend yield is 7.3%%.

What Is the Giant Biogene Holding Market Cap?

As of today, Giant Biogene Holding market cap is 20.01B HKD.

What Is Giant Biogene Holding's Earnings Per Share (TTM)?

The Giant Biogene Holding EPS (TTM) is 1.83.

From a Technical Analysis Perspective, Is 2367 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Giant Biogene Holding Stock Split?

Giant Biogene Holding has split 0 times.

How Many Employees Does Giant Biogene Holding Have?

Giant Biogene Holding has 2319 employees.

What is the current trading status of Giant Biogene Holding (2367)?

As of Nov 19, 2026, Giant Biogene Holding (2367) is trading at a price of 18.85 HKD, with a previous close of 18.85 HKD. The stock has fluctuated within a day range of 18.40 HKD to 19.10 HKD, while its 52-week range spans from 18.40 HKD to 41.32 HKD.

What Is Giant Biogene Holding (2367) Price Target According to Analysts?

The average 12-month price target for Giant Biogene Holding is 35.31 HKD, with a high estimate of 46 HKD and a low estimate of 20.7 HKD. 12 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Buy. The stock has an +87.31% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.